Oncology PracticePrognostic model has clinical utility in mCRPCSeptember 12, 2018Genitourinary CancerRenal Cell Carcinoma
Oncology PracticePD1 mRNA may predict response to anti-PD1 monotherapy across cancer typesSeptember 4, 2018Immuno-oncologyMelanomaLung CancerRenal Cell Carcinoma
Oncology PracticePatients with mRCC survive longer at high-volume centersSeptember 4, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeSunitinib for RCC: Side effects predictable, manageable, and reversibleAugust 31, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeSunitinib alone not inferior to nephrectomy-sunitinib in metastatic RCCAugust 27, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeStudy sheds new light on prognostic factors in PRCCAugust 24, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeHypofractionated radiation has untapped potential as RCC mets therapyAugust 22, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeIncreasing incidence of metastatic RCC raises concerns for SREsAugust 22, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeLeptin expression may help differentiate renal lesionsAugust 17, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeRenal hemangioma? Think againAugust 16, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticePlasma GAG provides prognostic info for RCCAugust 14, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeCT features associated with (some) ccRCC subtypesAugust 14, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeRare clear cell papillary RCC has indolent courseAugust 6, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeConditional OS estimates show upfront TKI benefit in mRCCAugust 3, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeGene assays reveal some ‘unknown primary’ cancers as RCCJuly 25, 2018Renal Cell CarcinomaGenitourinary Cancer
